Hypertension and type 2 diabetes: a cross-sectional study in Morocco (EPIDIAM Study)

Mohamed Berraho, Youness El Achhab, Abdelilah Benslimane, Karima El Rhazi, Mohamed Chikri, Chakib Nejjari, Mohamed Berraho, Youness El Achhab, Abdelilah Benslimane, Karima El Rhazi, Mohamed Chikri, Chakib Nejjari

Abstract

Background: In Morocco, there are no studies that focused on the hypertension and its associated risk factors through patients with type 2 diabetes. Different findings show that the frequency of type 2 diabetes has risen rapidly in Morocco. The main objective of this study was to assess the prevalence of hypertension and its associated risk factors among a group of patients with type 2 diabetes and to examine the level of control of hypertension among type 2 diabetic patients with hypertension.

Methods: A cross-sectional study was carried out on 525 type 2 diabetics in three Moroccan regions. The structured questionnaire was used to gather information on sociodemographic variables, history of hypertension, use of anti-hypertensive medications and duration of diabetes. Anthropometric measurements including weight and height were measured by trained staff. Blood pressure was measured using standardized sphygmomanometers.

Results: The prevalence of hypertension was 70.4%. The logistic regression indicated that hypertension was positively associated with age (p<10-4), BMI (p<0.0002) and duration of diabetes (p)

Conclusion: Hypertension is a common co-morbidity among Moroccan diabetic patients with high rate of ignorance of hypertension among study subjects. The focus must be on patients and family education, counseling and behavioral interventions designed to modify lifestyle such as increasing physical activity and adopting recommended dietary changes, as well as compliance with medications.

Keywords: Anthropometric measurements; Hypertension; Morocco; cross-sectional survey; diabetes; risk factors.

References

    1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998 Sep;21(9):1414–31.
    1. Genuth S. A case for blood glucose control. Advances in internal medicine. 1995;40:573–623.
    1. Libby P, Nathan DM, Abraham K, Brunzell JD. Report of the National Heart, Lung and Blood Institute: National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of DM. Circulation. 2005;111:3489–93.
    1. Paul B, Sapra B, Maheswari S, Goyal RK. Role of Losartan therapy in the management of diabetic hypertension. The Journal of the Association of Physicians of India. 2000;48:514–7.
    1. National High Blood Pressure Education Program Working Group report on hypertension in diabetes. Hypertension. 1994 Feb;23(2):145–58.
    1. Satman I, Yilmaz T. Population-based study of diabetes and risk characteristics in Turkey. Diabetes Care. 2002;25:1551–6.
    1. Tseng CH. Higher risk of hypertension in indigenous type 2 diabetic patients in Taiwan. Journal of Hypertension. 2006;24(9):1817–21.
    1. Baskar V, Kamalakannan D, Holland MR, Singh BM. The prevalence of hypertension and utilization of antihypertensive therapy in a district Diabettes Population. Diabetes Care. 2002;25:2107–8.
    1. Comaschi M, Coscelli C, Cucinotta D, Malini P, Manzato E, Nicolucci A. SFIDA Study Group–Italian Association of Diabetologists (AMD). Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study. Nutr Metab Cardiovasc Dis. 2005 Jun;15(3):204–11.
    1. Del Cañizo-Gómez FJ, Moreira-Andrés MN. Cardiovascular risk factors in patients with type 2 diabetes. Do we follow the guidelines? Diabetes Res Clin Pract. 2004 Aug;65(2):125–33.
    1. Baskar V, Kamalakannan D, Holland MR, Singh BM. Does ethnic origin have an independent impact on hypertension and diabetic complications? Diabetes Obes Metab. 2006 Mar;8(2):214–9.
    1. Fong DS, Aiello LP, Ferris FL, Klein R. Diabbetic retinopathy. Diabetes Care. 2004;27:2540–53.
    1. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH. EURODIAB Prospective Complications Study Group. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005 Jan 27;352(4):341–50.
    1. Sowers JR, Williams M, Epstein M, Bakris G. Hypertension in patients with diabetes: strategies for drug therapy to reduce complications. Postgraduate medicine. 2000;107:47–54.
    1. Sowers JR. “Treatment of hypertension in patients with diabetes”. Archives of internal medicine. 2004;164(17):1850–7.
    1. El-Atat F, McFarlane SI, Sowers JR. Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management. Current hypertension reports. 2004;6(3):215–23.
    1. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001;37(4):1053–9.
    1. Bakris G, Williams M, Dworkin L, Elliott W, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J. Preserving renal function in adults with hypertension and diabetes: A consensus approach. American journal of kidney diseases. 2000;36(3):646–61.
    1. Sowers JR, Haffner S. Treatment of cardiovascular and renal risk factors in the diabetic hypertensive. Hypertension. 2002;40(6):781–8.
    1. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. British medical journal. 2000;321(7258):412–9.
    1. Ministry of Health of Morocco. Santé en chiffres 2006–2010…;
    1. Tazi MA, Abir-Khalil S, Chaouki N, Cherqaoui S, Lahmouz F, Sraïri JE, Mahjour J. Prevalence of the main cardiovascular risk factors in Morocco: results of a National Survey, 2000. Journal of Hypertension. 2003;21(5):897–903.
    1. WHO. WHO: Geneva, Switzerland; 1995. The use and interpretation of anthropometry.
    1. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2009;32(Suppl 1):S13–61.
    1. Bener A, Zirie M, Janahi IM, Al-Hamaq AO, Musallam M, Wareham NJ. Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar. Diabetes Research and Clinical Practice. 2009;84(1):99–106.
    1. Mubarak FM, Froelicher ES, Jaddou HY, Ajlouni KM. Hypertension among 1000 patients with type 2 diabetes attending a national diabetes center in Jordan. Annals of Saudi medicine. 2008;28(5):346–51.
    1. Akbar DH, Ahmed MM, Algambi AA. Cardiovascular risk factors in Saudi and non-Saudi diabetics. Saudi Med J. 2003 Jun;24(6):686–7.
    1. Al-Moosa S, Allin S, Jemiai N, Al-Lawati J, Mossialos E. Diabetes and urbanization in the Omani population: an analysis of national survey data. Popul Health Metr. 2006 Apr 24;4:5.
    1. Al-Mahroos F, Al-Roomi K, McKeigue PM. Relation of high blood pressure to glucose intolerance, plasma lipids and educational status in an Arabian Gulf population. International journal of epidemiology. 2000;29:71–6.
    1. Davis TM, Stratton IM, Fox CJ, Holman RR, Turner RC. U.K. Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM. Diabetes Care. 1997 Sep;20(9):1435–41.
    1. Cowie CC, Harris MI. Physical and metabolic characteristics of persons with diabetes. Diabetes in America. In: Harris MI, editor. 2nd ed. Bethesda, Md: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Disease; 1995. pp. 117–164. NIH publication 95-1468.
    1. Sprafka JM, Bender AP, Jagger HG. Prevalence of hypertension and associated risk factors among diabetic individuals. The Three-City Study. Diabetes Care. 1988 Jan;11(1):17–22.
    1. No authors listed. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. Journal of Hypertension. 1993;11:309–17.
    1. Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 DM: the relation of obesity and age of onset. Diabetes Care. 2001;24(9):1522–7.
    1. Dentali F, Sharma AM, Douketis JD. Management of hypertension in overweight and obese patients: a practical guide for clinicians. Current Hypertension Reports. 2005;7:330–6.
    1. Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, Ernst ND, Horan M. Body mass index and the prevalence of hypertension and dyslipidemia. Obesity Research. 2000;8(9):605–19.
    1. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999 Oct 27;282(16):1523–9.
    1. Tsai AC, Liou JC, Chang MC. Interview to study the determinants of hypertension in older adults in Taiwan: a population based cross-sectional survey. Asia Pacific journal of clinical nutrition. 2007;16:338–45.
    1. Eguchi K, Ishikawa J, Hoshide S, Pickering TG, Shimada K, Kario K. Masked hypertension in diabetes mellitus: a potential risk. J Clin Hypertens (Greenwich) 2007 Aug;9(8):601–7.
    1. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004 Jan 21;291(3):335–42.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa